BIOMORPHIC
Conforms to and integrates with surrounding tissue to enable tissue reconstruction
PROGRAMMABLE
Polymer building blocks can be adjusted to match tissue-specific requirements
- Our polymer technology is based on the combination of safe, naturally occurring compounds, such as glycerol and sebacic acid.
- A viscous pre-polymer can be precisely applied to tissues, with minimal displacement by body fluids, during surgical procedures.
- The high viscosity of the pre-polymer allows it to be precisely applied with minimal displacement by body fluids.The viscous pre-polymer is activated on-demand, within seconds, using a visible blue light
- The resulting bond is both adhesive and elastic, allowing the polymer to comply with the underlying tissue while remaining strongly adhered.
- The pre-polymer can also be used as a resin to build high-resolution 3D-printed devices.
- The pre-polymer can also be loaded with drugs and deployed potentially anywhere in the body, creating a depot that elutes drugs locally for extended periods.
Tissue Sealants
We develop tissue sealants for use in cardiovascular procedures.
Tissue Adhesives
We develop tissue adhesives for use in peripheral nerve and gastrointestinal procedures.
3D-Printed Implants
We design surgical scaffolds using 3D printing technology for peripheral nerve repair.
Localized Drug Delivery
We formulate drug-eluting adhesives for the treatment of ENT diseases.
We are developing a portfolio of products to meet unmet clinical needs in tissue reconstruction
Tissue Reconstruction
We create solutions that have the potential to transform the way that tissue is repaired and restored. Below are some of the therapeutic areas that we are exploring.
Peripheral Nerve
We are developing a sutureless nerve reconstruction solution, by combining a 3D-printed implantable device and on-demand activated adhesive.
Gastrointestinal
We are advancing pre-clinical testing of an adhesive for use in hernia repair and a solution to improve patient outcomes for patients with inflammatory bowel disease.
Ear, Nose, Throat
We are leveraging the drug delivery capabilities of our polymer to develop solutions for ENT diseases.
Cardiovascular
We received CE Mark in 2017 for our first product, a vascular sealant used as an adjunct to sutures to achieve immediate hemostasis in peripheral vascular surgery.
Co-Development
Our on-going projects are just the beginning. We are actively seeking co-development opportunities to fully leverage the potential of our biomorphic programmable polymer platform.